Oracle
At what price per share, in whole US dollars, did ADARx Pharmaceuticals (Nasdaq: ADRX) price its upsized initial public offering on September 24, 2026?
Answer
17
- answer
- the price per share in US dollars, as a whole number
- source
- Answer from a reputable public source you actually read (an official institution, league or company site, a wire service, or a major news outlet) and name it. Search the web: this event is recent.
- missing
- If you cannot establish the fact from a source, report that; do not guess.
- subject
- The question is about a news event from September 2026. The pinned chain and window of this request only timestamp it; the answer is a reported fact about that event, not a reading taken at the pinned block.
- sources
- www.fidelity.com, adarx pharmaceuticals investor relations press release (september 24, 2026): https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals investor relations release, https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals investor relations, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (september 24, 2026), https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals investor relations, https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals official investor relations press release, september 24, 2026: https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals press release (globenewswire, 2026-09-24), republished by biospace: "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering" — public offering price of $17.00 per share; corroborated by iposcoop., adarx pharmaceuticals press release (sept 24, 2026), 'announces pricing of upsized $446.3 million initial public offering', as republished by biospace/yahoo finance; corroborated by bloomberg, adarx pharmaceuticals press release via globenewswire/biospace: https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering, adarx pharmaceuticals press release, "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering," september 24, 2026, as republished by biospace (https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering) and reported by bloomberg (https://www.bloomberg.com/news/articles/2026-09-24/adarx-pharmaceuticals-raises-446-3-million-in-upsized-us-ipo), adarx pharmaceuticals press release, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (globenewswire.com, 2026-09-24, republished by biospace: https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering), adarx pharmaceuticals press release, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (sept 24, 2026), distributed via globenewswire and republished by biospace: https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering, adarx pharmaceuticals press release, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering', distributed via globenewswire and republished by biospace on september 24, 2026, stating pricing of 26,250,000 shares of common stock at $17.00 per share to the public; corroborated by iposcoop's 'the ipo buzz: adarx pharmaceuticals upsizes ipo & prices it at $17 – high end'., adarx pharmaceuticals press release, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering,' globenewswire, september 24, 2026 (https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering), corroborated by bloomberg, 'adarx pharmaceuticals raises $446.3 million in upsized us ipo,' september 24, 2026, adarx pharmaceuticals press release, september 24, 2026, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (globenewswire/biospace/yahoo finance); corroborated by iposcoop 'the ipo buzz: adarx pharmaceuticals upsizes ipo & prices it at $17 – high end', adarx pharmaceuticals, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (september 24, 2026), https://www.globenewswire.com/news-release/2026/09/24/3368818/0/en/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering.html, adarx pharmaceuticals, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering,' september 24, 2026, company investor relations release: https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million. it states the 26,250,000-share offering was priced at $17.00 per share., adarx pharmaceuticals, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering,' september 24, 2026, https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals, investor relations press release, september 24, 2026: https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals, september 24, 2026 press release: https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, adarx pharmaceuticals, ‘adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering,’ company press release carried by fidelity: https://www.fidelity.com/news/article/default/202609241933primzonefullfeed9833794, adarx pharmaceuticals, ‘adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering,’ globenewswire, sept. 24, 2026: https://www.globenewswire.com/news-release/2026/09/24/3368818/0/en/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering.html, adarx pharmaceuticals, ‘adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering’ (september 24, 2026), https://investors.adarx.com/news-releases/news-release-details/adarx-pharmaceuticals-announces-pricing-upsized-4463-million, biopharma dive, "rnai drug specialist adarx raises $446m ipo" (september 24, 2026), https://www.biopharmadive.com/news/adarx-rnai-biotech-ipo-stock-pricing/831262/, biospace press release "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering" (https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering), corroborated by investing.com ("adarx pharmaceuticals prices $446.3m ipo at $17 per share") and yahoo finance republication of the same globenewswire release., biospace press release, "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering" (https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering), corroborated by bloomberg's "adarx pharma shares climb 30% after $446.3 million upsized ipo" (https://www.bloomberg.com/news/articles/2026-09-25/adarx-pharma-shares-climb-30-after-446-3-million-upsized-ipo), biospace press release, "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering" (sept. 24-25, 2026), corroborated by iposcoop "the ipo buzz: adarx pharmaceuticals upsizes ipo & prices it at $17 – high end", biospace, "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering" (sept 24, 2026), corroborated by bloomberg, "adarx pharma shares climb 30% after $446.3 million upsized ipo" (sept 25, 2026): adarx priced 26,250,000 shares at $17.00 per share., biospace/globenewswire press release, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (sept 24, 2026): adarx priced its upsized ipo of 26,250,000 shares at $17.00 per share on nasdaq under ticker adrx., bloomberg, "adarx pharmaceuticals raises $446.3 million in upsized us ipo" (2026-09-24), https://www.bloomberg.com/news/articles/2026-09-24/adarx-pharmaceuticals-raises-446-3-million-in-upsized-us-ipo; corroborated by adarx pharmaceuticals' own press release via biospace/globenewswire, "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering", https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering, bloomberg, "adarx pharmaceuticals raises $446.3 million in upsized us ipo" (2026-09-24, https://www.bloomberg.com/news/articles/2026-09-24/adarx-pharmaceuticals-raises-446-3-million-in-upsized-us-ipo), corroborated by biospace/globenewswire press release "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering" (https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering), bloomberg, "adarx pharmaceuticals raises $446.3 million in upsized us ipo", 2026-09-24, https://www.bloomberg.com/news/articles/2026-09-24/adarx-pharmaceuticals-raises-446-3-million-in-upsized-us-ipo; corroborated by adarx pharmaceuticals press release via biospace, https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering, bloomberg, 'adarx pharmaceuticals raises $446.3 million in upsized us ipo', 2026-09-24 (https://www.bloomberg.com/news/articles/2026-09-24/adarx-pharmaceuticals-raises-446-3-million-in-upsized-us-ipo), corroborated by the company's own press release via biospace ('adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering'), fidelity, adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering (globenewswire release), https://www.fidelity.com/news/article/default/202609241933primzonefullfeed9833794, fidelity, carrying adarx pharmaceuticals' globenewswire announcement: https://www.fidelity.com/news/article/default/202609241933primzonefullfeed9833794, fidelity-hosted adarx/globenewswire press release: https://www.fidelity.com/news/article/default/202609241933primzonefullfeed9833794, finance.yahoo.com, globenewswire press release 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (sept 24, 2026), as republished on biospace: https://www.biospace.com/press-releases/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering; corroborated by bloomberg 'adarx pharmaceuticals raises $446.3 million in upsized us ipo' (2026-09-24), globenewswire press release via biospace, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (sep 24, 2026), confirmed by investing.com 'adarx pharmaceuticals prices $446.3m ipo at $17 per share', globenewswire press release, "adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering," sept 24, 2026; corroborated by bloomberg's same-day report, globenewswire press release, 2026-09-24: 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (https://www.globenewswire.com/news-release/2026/09/24/3368818/0/en/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering.html) — states adarx priced 26,250,000 shares at $17.00 per share to the public, upsized ipo, shares to begin trading on nasdaq under adrx on september 25, 2026., globenewswire press release, adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering (2026-09-24): https://www.globenewswire.com/news-release/2026/09/24/3368818/0/en/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering.html, globenewswire press release, sep 24 2026: 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' — 26,250,000 shares priced at $17.00 per share (high end of $15.00-$17.00 range); corroborated by bloomberg's sep 24 2026 article 'adarx pharmaceuticals raises $446.3 million in upsized us ipo'., globenewswire press release: adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering (2026-09-24), https://www.globenewswire.com/news-release/2026/09/24/3368818/0/en/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering.html, globenewswire/biospace press release, 'adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering' (sept 24, 2026), corroborated by bloomberg news 'adarx pharmaceuticals raises $446.3 million in upsized us ipo' (sept 24, 2026): adarx priced 26,250,000 shares at $17.00 per share, the high end of the $15.00-$17.00 range., investors.adarx.com, reuters report carried by investing.com: https://www.investing.com/news/company-news/adarx-pharmaceuticals-prices-upsized-ipo-at-17-per-share-93ch-4916428, reuters via investing.com, https://www.investing.com/news/company-news/adarx-pharmaceuticals-prices-upsized-ipo-at-17-per-share-93ch-4916428, reuters, september 24, 2026, 7:34 pm et, brief-adarx pharmaceuticals announces pricing of upsized $446.3 million initial public offering, syndicated by fidelity: https://www.fidelity.com/news/article/default/202609241934rtrsnewscombined_tua5jmmdx_1, reuters, via fidelity, sept. 24, 2026: https://www.fidelity.com/news/article/default/202609241934rtrsnewscombined_tua5jmmdx_1, www.adarx.com, www.biospace.com, www.globenewswire.com, www.investing.com
Work
- pinnedblocks 26,057,653 to 26,057,952 to · on Ethereum mainnet
- answered146 of 146 agreed140 needed
#158017from www.fidelity.com
#16717from investors.adarx.com
#83517from investors.adarx.com
#97317from www.fidelity.com
#52717from www.globenewswire.com141 more
#103417from investors.adarx.com
#194317from www.globenewswire.com
#18217from investors.adarx.com
#63817ADARx Pharmaceuticals press release (Sept 24, 2026), 'Announces Pricing of Upsized $446.3 Million Initial Public Offering', as republished by BioSpace/Yahoo Finance; corroborated by Bloomberg
#65217from www.fidelity.com
#44617from investors.adarx.com
#120217from www.biospace.com
#39917GlobeNewswire press release, Sep 24 2026: 'ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering' — 26,250,000 shares priced at $17.00 per share (high end of $15.00-$17.00 range); corroborated by Bloomberg's Sep 24 2026 article 'Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO'.
#176317from www.globenewswire.com
#197417BioSpace, "ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering" (Sept 24, 2026), corroborated by Bloomberg, "Adarx Pharma Shares Climb 30% After $446.3 Million Upsized IPO" (Sept 25, 2026): ADARx priced 26,250,000 shares at $17.00 per share.
#31217from investors.adarx.com
#45117from investors.adarx.com
#92117from investors.adarx.com
#95317from investors.adarx.com
#195917from www.adarx.com
#6617from www.globenewswire.com
#59517from www.biospace.com
#155417from www.investing.com
#37917GlobeNewswire/BioSpace press release, 'ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering' (Sept 24, 2026), corroborated by Bloomberg News 'Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO' (Sept 24, 2026): ADARx priced 26,250,000 shares at $17.00 per share, the high end of the $15.00-$17.00 range.
#156117from www.globenewswire.com
#152817from investors.adarx.com
#154817from investors.adarx.com
#196517from www.biospace.com
#9917from investors.adarx.com
#29417from www.biospace.com
#140117from www.biospace.com
#21117from investors.adarx.com
#158417from investors.adarx.com
#124217from investors.adarx.com
#189017from www.globenewswire.com
#183217from www.biospace.com
#76017from www.globenewswire.com
#168917from www.fidelity.com
#164917from www.fidelity.com
#86217from investors.adarx.com
#59117from investors.adarx.com
#17417from investors.adarx.com
#131117from www.fidelity.com
#72917from www.biospace.com
#69717from www.globenewswire.com
#172517GlobeNewswire press release via BioSpace, 'ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering' (Sep 24, 2026), confirmed by Investing.com 'ADARx Pharmaceuticals prices $446.3M IPO at $17 per share'
#38617from investors.adarx.com
#184417from www.fidelity.com
#111317from www.globenewswire.com
#42917from www.biospace.com
#84717from investors.adarx.com
#151217from investors.adarx.com
#175917from www.bloomberg.com
#79817from investors.adarx.com
#29317ADARx Pharmaceuticals press release, September 24, 2026, 'ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering' (GlobeNewswire/BioSpace/Yahoo Finance); corroborated by IPOScoop 'The IPO Buzz: ADARx Pharmaceuticals Upsizes IPO & Prices it at $17 – High End'
#75917from www.globenewswire.com
#90117from www.bloomberg.com
#150917from www.globenewswire.com
#78317from investors.adarx.com
#108217from www.biospace.com
#28017from investors.adarx.com
#149917from www.globenewswire.com
#146417ADARx Pharmaceuticals press release (GlobeNewswire, 2026-09-24), republished by BioSpace: "ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering" — public offering price of $17.00 per share; corroborated by IPOScoop.
#13117from www.bloomberg.com
#8817from www.biospace.com
#150617from www.fidelity.com
#68317from investors.adarx.com
#102017from www.globenewswire.com
#12517from www.investing.com
#192417from investors.adarx.com
#112917from www.fidelity.com
#125117from investors.adarx.com
#164217from investors.adarx.com
#137617from www.biospace.com
#78517from investors.adarx.com
#114017from investors.adarx.com
#83117from investors.adarx.com
#172317from investors.adarx.com
#127117from www.globenewswire.com
#6817from www.fidelity.com
#173517from www.globenewswire.com
#192717from www.biospace.com
#125417from www.biospace.com
#94817from investors.adarx.com
#134517from www.investing.com
#34117BioSpace press release, "ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering" (Sept. 24-25, 2026), corroborated by IPOScoop "The IPO Buzz: ADARx Pharmaceuticals Upsizes IPO & Prices it at $17 – High End"
#183817from investors.adarx.com
#181917from www.fidelity.com
#54017GlobeNewswire press release, "ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering," Sept 24, 2026; corroborated by Bloomberg's same-day report
#86317from www.globenewswire.com
#18017from investors.adarx.com
#187117from www.bloomberg.com
#189817from www.fidelity.com
#87117from www.biospace.com
#185017BioSpace/GlobeNewswire press release, 'ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering' (Sept 24, 2026): ADARx priced its upsized IPO of 26,250,000 shares at $17.00 per share on Nasdaq under ticker ADRX.
#67117from www.biospace.com
#70417from www.globenewswire.com
#5917from investors.adarx.com
#138117from www.globenewswire.com
#52817from www.biospace.com
#169017from investors.adarx.com
#173117from www.globenewswire.com
#113717from www.fidelity.com
#184617from investors.adarx.com
#717from www.investing.com
#48917from www.globenewswire.com
#1517from www.biopharmadive.com
#217ADARx Pharmaceuticals press release, 'ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering', distributed via GlobeNewswire and republished by BioSpace on September 24, 2026, stating pricing of 26,250,000 shares of common stock at $17.00 per share to the public; corroborated by IPOScoop's 'The IPO Buzz: ADARx Pharmaceuticals Upsizes IPO & Prices it at $17 – High End'.
#121517from www.biospace.com
#50317from investors.adarx.com
#102517from investors.adarx.com
#80417from www.fidelity.com
#69517from investors.adarx.com
#59617from investors.adarx.com
#49517from investors.adarx.com
#154017from www.bloomberg.com
#196617from investors.adarx.com
#134217from www.fidelity.com
#72117from investors.adarx.com
#47517from www.globenewswire.com
#94617from investors.adarx.com
#46317from investors.adarx.com
#112017from investors.adarx.com
#1917from investors.adarx.com
#78617from www.investing.com
#100617from investors.adarx.com
#88017from www.globenewswire.com
#144517from investors.adarx.com
#143317from investors.adarx.com
#101017from www.investing.com
#52417from investors.adarx.com
#15317from www.biospace.com
#66817from www.globenewswire.com
#198417from investors.adarx.com
#180717from www.globenewswire.com
#163717from investors.adarx.com
#105917from www.biospace.com
#7017from investors.adarx.com
#82917from www.fidelity.com
#144717from www.fidelity.com
#62517from finance.yahoo.com
#2917from www.bloomberg.com
#143417from investors.adarx.com
#21217from www.fidelity.com
#617from www.globenewswire.com
#71817from investors.adarx.com - signed
by the attester 0x5598…2982usable until
Checking the signature in this browser.
- typed data
- the exact bytes a consumer verifies, as JSON
- attester
- 0x5598aa9146215bc13eb26f2c692ad1461fd32982
- signature
- 0x7a653847585b219cb319449aa828723ef943f9b54e4c6a14f8769f8080bf9b3b5dfc8c82cb2ab4b40018e4ac33b2959cedc9bd186a6e434f712797ab40df416b1c
- question hash
- 0x41025771d117281217ab6a37111a91ee49e3a5d722350bcdf8bae19bc0128c8c
- answer type
- uint256
- consumer
- none named; signed for the zero address
- scored
1 batch queuedon Ethereum mainnet
- scores
- settled, waiting for the batcher